Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuromatrix is a neurotechnology company commercializing a non-invasive photobiomodulation headset aimed at brain wellness, cognitive performance, mood, and sleep support. Its flagship Neuromatrix Headset delivers targeted pulsed near-infrared light to the head to stimulate mitochondrial activity and support neurostimulation-related effects. The company positions its product as a science-backed brain optimization tool for home use rather than a drug developer with a traditional therapeutic pipeline. Public-facing materials emphasize applications in focus, emotional resilience, meditation, recovery, and general brain health, while noting that the headset is not marketed as a medical device for treatment of specific diseases. Overall, Neuromatrix appears to operate at the intersection of consumer neurotechnology, wellness, and light-based brain stimulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuromatrix.